Benzinga | Apr 27, 2021 06:57AM EDT

Citigroup Initiates Coverage On Arena Pharmaceuticals with Buy Rating, Announces Price Target of $104

Citigroup analyst Neena Bitritto-Garg initiates coverage on Arena Pharmaceuticals (NASDAQ:ARNA) with a Buy rating and announces Price Target of $104.